Genes, cardiovascular health each factor into dementia risk
Genes and cardiovascular health each contribute in an additive way to a person’s risk of dementia, researchers including Sudha Seshadri, MD, and Claudia Satizabal, PhD, of UT Health San Antonio reported July 20 in the journal Neurology.
The study was conducted in 1,211 participants in the Framingham Heart Study and involved collaborators from Boston University.
Participants with a high genetic risk score based on common genetic variants, including having an allele called apolipoprotein E (APOE) ε4, were at a 2.6-fold higher risk of developing dementia than subjects who had a low risk score and did not carry the APOE ε4 allele.
Having favorable cardiovascular health, as defined by an index of the American Heart Association, was associated with a 0.45-fold lower risk of dementia compared to having unfavorable cardiovascular health, the study also showed.
“The connection between heart health and brain health becomes clearer with each finding,” Dr. Seshadri, senior investigator in the Framingham Heart Study, said. She is professor of neurology in the Long School of Medicine at UT Health San Antonio and founding director of the university’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases.
“We hope that the results of this study will send the public a message, and that message is to exercise, reduce stress and eat a healthy diet,” Dr. Seshadri said. “Then, regardless of your genes, you have the potential to lower your risk of dementia.”
“It is imperative to start today,” Dr. Satizabal, assistant professor of population health sciences and Biggs Institute investigator, said. “It seems, from our findings, that having favorable cardiovascular health mitigates the risk of dementia in persons with high genetic risk.”
# # #
Funding for the UT Health San Antonio investigators is from the National Institutes of Health.
Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study
Gina M. Peloso, PhD; Alexa S. Beiser, PhD; Claudia L. Satizabal, PhD; Vanessa Xanthakis, PhD; Ramachandran S. Vasan, MD; Matthew P. Pase, PhD; Anita L. Destefano, PhD; and Sudha Seshadri, MD
First published: July 20, 2020, Neurology
The Long School of Medicine at The University of Texas Health Science Center at San Antonio is named for Texas philanthropists Joe R. and Teresa Lozano Long. The school is the largest educator of physicians in South Texas, many of whom remain in San Antonio and the region to practice medicine. The school teaches more than 900 students and trains 800 residents each year. As a beacon of multicultural sensitivity, the school annually exceeds the national medical school average of Hispanic students enrolled. The school’s clinical practice is the largest multidisciplinary medical group in South Texas with 850 physicians in more than 100 specialties. The school has a highly productive research enterprise where world leaders in Alzheimer’s disease, diabetes, cancer, aging, heart disease, kidney disease and many other fields are translating molecular discoveries into new therapies. The Long School of Medicine is home to a National Cancer Institute-designated cancer center known for prolific clinical trials and drug development programs, as well as a world-renowned center for aging and related diseases.
The University of Texas Health Science Center at San Antonio, also referred to as UT Health San Antonio, is one of the country’s leading health sciences universities and is designated as a Hispanic-Serving Institution by the U.S. Department of Education. With missions of teaching, research, patient care and community engagement, its schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have graduated more than 37,000 alumni who are leading change, advancing their fields, and renewing hope for patients and their families throughout South Texas and the world. To learn about the many ways “We make lives better®,” visit www.uthscsa.edu.